
Biden Pledges Enough COVID-19 Vaccines for All US Adults By End of May
President Biden promised that the federal government will have enough vaccine supply to vaccinate approximately 300 million Americans by the end of May.
President Biden today promised that the federal government will have enough doses of the COVID-19 vaccine to vaccinate approximately 300 million Americans by the end of May, which is 2 months earlier than anticipated.1,2
The news follows an agreement between the Biden administration and Merck that will allow the company to assist in manufacturing Johnson & Johnson’s recently-authorized 1-dose vaccine.3,4 Earlier today, Press Secretary Jen Psaki said that the US government will invoke the Defense Production Act to equip 2 Merck facilities to the standards necessary to safely manufacture the vaccine.4 According to a Merck press release, the company will use its US facilities to produce drug substance, formulate, and fill vials of the vaccine for distribution.3
The
Related:
Biden also announced during his remarks that he will direct all states to prioritize vaccinating teachers, challenging states to administer at least 1 dose of the vaccine to all educators by the end of March. Biden said that the government will provide the doses directly through its pharmacy program. Teachers will be able to sign up directly through participating retail pharmacies in their local area, according to the administration.1,2
As part of the
Starting next week, the Biden administration also announced that the federal government was increasing the supply of Moderna and Pfizer vaccines to states to 15.2 million doses per week, up from 14.5 million previously. Furthermore, states are also receiving 2.8 million of the Johnson & Johnson vaccine this week.3
Reference
1. White House Press Briefing. President Biden Delivers Remarks on the Ongoing COVID-19 Pandemic. March 2, 2021.
2. Miller Z, Johnson LA, Lemire J. Biden vows enough vaccine for all US adults by end of May. Published March 2, 2021. Accessed March 2, 2021.
3. The White House. Press Briefing by Press Secretary Jen Psaki, March 2, 2021.
4. Merck to Help Produce Johnson & Johnson’s COVID-19 Vaccine; BARDA to Provide Merck With Funding to Expand Merck’s Manufacturing Capacity for COVID-19 Vaccines and Medicines. News release. Merck; March 2, 2021. Accessed March 2, 2021.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.